K2 HealthVentures Equity Trust LLC - 31 Dec 2024 SCHEDULE 13G/A Report for TScan Therapeutics, Inc. Voting Common Stock, $0.0001 par value per share (TCRX)

Filing Manager
K2 HealthVentures Equity Trust LLC
Reporting Manager
K2 HealthVentures Equity Trust LLC
Security
TScan Therapeutics, Inc. Voting Common Stock, $0.0001 par value per share
Symbol
TCRX
Shares outstanding
52,213,043 shares
Disclosed Ownership
3,602,700 shares
Ownership
6.9%
Form type
SCHEDULE 13G/A
Filing time
14 Feb 2025, 16:33:04 UTC
Date of event
31 Dec 2024
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
K2 HealthVentures Equity Trust LLC 6.9% 3,602,700 0 3,602,700 /s/ Anup Arora Anup Arora, Managing Member
Parag Shah 6.9% 3,602,700 0 3,602,700 /s/ Parag Shah Parag Shah
Anup Arora 6.9% 3,602,700 0 3,602,700 /s/ Anup Arora Anup Arora